Serum Laminin and Collagen IV in Inflammatory Bowel Disease

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2003 Nov 6

PMID 14600124

Citations 16

Authors

I E Koutroubakis

E Petinaki

P Dimoulios

E Vardas

M Roussomoustakaki

A N Maniatis

E A Kouroumalis

Affiliations

Soon will be listed here.

Abstract

Background: /

Aims: Laminin and collagen IV have been proposed as extracellular matrix serum markers. Because fibrosis is a major complication of inflammatory bowel disease, serum concentrations of laminin and collagen IV were measured in patients with ulcerative colitis (UC) and Crohn's disease (CD) and compared with inflammatory and healthy controls.

Methods: Laminin and collagen IV serum concentrations were measured in 170 patients with inflammatory bowel disease (86 UC and 84 CD), in 23 patients with other causes of intestinal inflammation, and in 80 matched healthy controls using commercially available enzyme linked immunosorbent assays. Laminin and collagen IV concentrations were correlated with disease activity, type, localisation, and treatment.

Results: Mean (SD) serum laminin concentrations were 281.0 (110.1) ng/ml in patients with UC, 275.6 (106.7) ng/ml in patients with CD, 192.0 (17.8) ng/ml in healthy controls, and 198.5 (32.5) ng/ml in inflammatory controls. Mean (SD) serum collagen IV concentrations were 72.8 (22.9) ng/ml in patients with UC, 71.0 (18.2) in patients with CD, 79.8 (12.2) ng/ml in healthy controls, and 88.9 (24.6) ng/ml in inflammatory controls. There was a significant difference among the four groups (p < 0.0001) for both markers. There was a strong correlation between serum laminin, but not collagen IV, and disease activity in both diseases. No significant association was found between these markers and disease localisation or disease type.

Conclusions: Serum concentrations of laminin are increased, whereas serum concentrations of collagen IV are decreased, in patients with inflammatory bowel disease. They may be useful surrogate markers for sustained inflammation and tissue remodelling.

Citing Articles

Gut microbiota induced abnormal amino acids and their correlation with diabetic retinopathy.

Jiang S, Ye S, Huang Y, Ou Y, Chen K, Chen J Int J Ophthalmol. 2024; 17(5):883-895.

PMID: 38766339 PMC: 11074191. DOI: 10.18240/ijo.2024.05.13.

Precision medicine and drug optimization in adult inflammatory bowel disease patients.

Vieujean S, Louis E Therap Adv Gastroenterol. 2023; 16:17562848231173331.

PMID: 37197397 PMC: 10184262. DOI: 10.1177/17562848231173331.

Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases.

Komosinska-Vassev K, Kaluzna A, Jura-Poltorak A, Derkacz A, Olczyk K J Clin Med. 2022; 11(19).

PMID: 36233486 PMC: 9570505. DOI: 10.3390/jcm11195618.

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.

Bourgonje A, Alexdottir M, Otten A, Loveikyte R, Bay-Jensen A, Pehrsson M Aliment Pharmacol Ther. 2022; 56(4):675-693.

PMID: 35661188 PMC: 9544881. DOI: 10.1111/apt.17063.

The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases.

Derkacz A, Olczyk P, Olczyk K, Komosinska-Vassev K J Clin Med. 2021; 10(5).

PMID: 33800267 PMC: 7962650. DOI: 10.3390/jcm10051122.

References

Pucilowska J, Williams K, Lund P . Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol. 2000; 279(4):G653-9. DOI: 10.1152/ajpgi.2000.279.4.G653. View

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

Heikius B, Niemela O, Niemela S, Karttunen T, Lehtola J . Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction. Hepatogastroenterology. 2002; 49(44):404-11. View

Walmsley R, Ayres R, Pounder R, Allan R . A simple clinical colitis activity index. Gut. 1998; 43(1):29-32. PMC: 1727189. DOI: 10.1136/gut.43.1.29. View

Schmehl K, Florian S, Jacobasch G, Salomon A, Korber J . Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorectal Dis. 2000; 15(1):39-48. DOI: 10.1007/s003840050006. View

Lennard-Jones J . Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170:2-6; discussion 16-9. DOI: 10.3109/00365528909091339. View

Kjeldsen J, Schaffalitzky de Muckadell O, Junker P . Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut. 1995; 37(6):805-10. PMC: 1382943. DOI: 10.1136/gut.37.6.805. View

Walsh K, Fletcher A, MacSween R, Morris A . Basement membrane peptides as markers of liver disease in chronic hepatitis C. J Hepatol. 2000; 32(2):325-30. DOI: 10.1016/s0168-8278(00)80079-3. View

Nakano T, Iwahashi N, Maeda J, Hada T, Higashino K . Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis?. Br J Cancer. 1992; 65(4):608-12. PMC: 1977574. DOI: 10.1038/bjc.1992.123. View

10.

Gelbmann C, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W . Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut. 1999; 45(2):210-7. PMC: 1727598. DOI: 10.1136/gut.45.2.210. View

11.

Burgmann H, Hollenstein U, Maca T, Thalhammer F, Koppensteiner R, Ehringer H . Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. J Clin Pathol. 1996; 49(6):508-10. PMC: 500545. DOI: 10.1136/jcp.49.6.508. View

12.

Lawrance I, Maxwell L, Doe W . Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis. 2001; 7(1):16-26. DOI: 10.1097/00054725-200102000-00003. View

13.

Horslev-Petersen K, Bentsen K, Halberg P, Junker P, Kivirikko K, Majamaa K . Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. 1988; 6(2):129-34. View

14.

Lawrance I, Maxwell L, Doe W . Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis. 2001; 7(3):226-36. DOI: 10.1097/00054725-200108000-00008. View

15.

Timpl R, Rohde H, Robey P, Rennard S, Foidart J, Martin G . Laminin--a glycoprotein from basement membranes. J Biol Chem. 1979; 254(19):9933-7. View

16.

Kjeldsen J, Rasmussen M, Schaffalitzky de Muckadell O, Kronborg O, Junker P . Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease. Scand J Gastroenterol. 2001; 36(11):1193-7. DOI: 10.1080/00365520152584833. View